Filing Details
- Accession Number:
- 0001179110-17-002952
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-22 17:57:52
- Reporting Period:
- 2017-02-17
- Filing Date:
- 2017-02-22
- Accepted Time:
- 2017-02-22 17:57:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1328034 | M John Capek | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2017-02-17 | 14,273 | $0.00 | 288,797 | No | 4 | A | Direct | |
Common Shares Without Par Value | Acquisiton | 2017-02-21 | 93,400 | $26.70 | 382,197 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2017-02-21 | 93,400 | $45.00 | 288,797 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Acquisiton | 2017-02-17 | 98,714 | $0.00 | 98,714 | $44.40 |
Common Shares | Option (right to buy) | Acquisiton | 2017-02-21 | 93,400 | $0.00 | 93,400 | $26.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
98,714 | 2018-02-17 | 2027-02-16 | No | 4 | A | Direct |
0 | 2011-02-08 | 2018-02-14 | No | 4 | M | Direct |
Footnotes
- These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 32,905 on 2/17/2018, 32,904 on 2/17/2019, and 32,905 on 2/17/2020.
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.